Quantum Computing Inc. (NASDAQ: QUBT), also known as QCi, is gaining commercial traction through its NeuraWave photonic reservoir computing platform targeting edge AI workloads.
Photonic reservoir computing has emerged as a compelling architecture for processing complex, time-sensitive data directly at the point of generation, without relying on centralized infrastructure.
QCi’s NeuraWave platform is specifically designed to handle temporal AI and time-series machine learning workloads, where speed, power efficiency, and edge analytics are critical priorities.
The architecture is particularly well-suited for distributed AI deployments at the network edge, where transferring large volumes of data to centralized computing resources is impractical or undesirable.
QCi recently received a purchase order and entered into a framework agreement with Planck Dynamics to deploy the NeuraWave system as a foundational platform for next-generation AI applications.
Under the agreement, QCi received an initial purchase order for five NeuraWave systems, with delivery expected during 2026 as the first phase of the commercial rollout.
The framework agreement is structured to support scaled deployment of NeuraWave systems as end-user milestones are achieved, representing a potential aggregate program value in excess of $10 million.
The deal represents a significant commercial milestone for QCi and further validates growing market interest in photonic computing technologies for AI applications across distributed environments.
On the peer front, D-Wave Quantum Inc. (NYSE: QBTS) announced a forthcoming gate-model quantum computing simulator built around its dual-rail technology, expected to be the first of its kind designed for error-aware programming.
Separately, Rigetti Computing, Inc. (NASDAQ: RGTI) signed a letter of intent with the U.S. Department of Commerce for an award of up to $100 million in funding over three years to accelerate superconducting quantum computing research and development.
Despite the commercial progress at QCi, QUBT shares have plunged 40.1% over the past year, compared with the broader industry’s decline of 22.1%, reflecting persistent investor skepticism toward early-stage quantum companies.
QUBT currently trades at a forward 12-month price-to-sales ratio of 87.38X, a significant premium compared with the industry median of 4.97X, underscoring the stock’s elevated valuation relative to peers.
QCi’s loss per share estimate for 2026 has remained unchanged at 14 cents over the past 30 days, suggesting analyst expectations have stabilized around the company’s near-term financial trajectory.
QUBT currently carries a Zacks Rank of number 2, designated as a Buy, reflecting a cautiously optimistic near-term outlook despite the stock’s steep valuation and recent share price underperformance.
